mpMRI Prostate Staging With Segmentation-Guided Classification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing prostate cancer staging methods, particularly using multi-parametric magnetic resonance imaging (mpMRI) and machine learning, face challenges in accurately localizing cancer without increasing the risk of misdiagnosis and burdening patients with unnecessary surgical interventions.

Innovation Solution

A machine learning model comprising segmentation and classification units is trained using multi-parametric MRI images to segment prostate and extra-prostatic lesions, then classify the local stage, reducing misdiagnosis risk by enhancing accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If machine learning methods are used to detect and classify prostate cancer based on mpMRI images, then diagnostic accuracy is improved, but device complexity increases

Engineering Contradiction:
Improvediagnostic accuracyVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The machine learning model is divided into multiple specialized components: a first segmentation unit for localizing the prostate gland, a second segmentation unit for segmenting cancer lesions, and a classification unit for determining cancer stage. This segmentation of functionality allows each component to specialize in a specific task, improving overall diagnostic accuracy while organizing complexity into manageable modular units that can be independently optimized and validated.

Inventive Principle:
Principle #1Segmentation

2Measurement precision

If multi-parametric MRI is used for local staging of prostate cancer, then measurement precision is improved, but loss of time increases

Engineering Contradiction:
Improvelocal staging accuracyVSAvoidexamination time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The first segmentation unit performs preliminary localization of the prostate gland before the second segmentation unit segments the cancer lesions. This preliminary action establishes accurate anatomical boundaries and context, which accelerates the subsequent lesion detection and staging processes. By pre-processing and organizing the anatomical structure first, the system reduces the computational time required for the more complex cancer segmentation and classification tasks.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If automated machine learning systems are implemented for prostate cancer staging, then productivity is improved, but reliability may worsen due to increased risk of misdiagnosis

Engineering Contradiction:
Improvestaging efficiencyVSAvoidmisdiagnosis risk
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The system incorporates multiple feedback mechanisms to ensure reliability: the segmented prostate gland from the first segmentation unit provides spatial feedback to constrain and guide the second segmentation unit's cancer lesion detection; the classified cancer stage feeds back to validate the segmentation results; and the trained model parameters are continuously refined through training on labeled datasets. These feedback loops ensure that automated processing maintains high reliability by constantly validating results at each processing stage.

Inventive Principle:
Principle #23Feedback

Data Source

PatentUS20260051049A1Prostate cancer local staging
Publication Date: 2026.02.19 BAYER AG
  • US20260051049A1 patent drawing
  • US20260051049A1 patent drawing
  • US20260051049A1 patent drawing

AI summary

Systems, methods, and computer programs disclosed herein relate to prostate cancer local staging based on multi-parametric magnetic resonance imaging images using a trained machine learning model.